Total Payments
$21,484
2024 Payments
$19,048
Companies
18
Transactions
136
Medicare Patients
831
Medicare Billing
$214,440
Payment Breakdown by Category
Other$14,500 (67.5%)
Food & Beverage$3,246 (15.1%)
Travel$2,839 (13.2%)
Consulting$840.00 (3.9%)
Education$58.65 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,500 | 7 | 67.5% |
| Food and Beverage | $3,246 | 115 | 15.1% |
| Travel and Lodging | $2,839 | 12 | 13.2% |
| Consulting Fee | $840.00 | 1 | 3.9% |
| Education | $58.65 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARGENX US, INC. | $18,588 | 38 | $0 (2024) |
| ABBVIE INC. | $1,019 | 48 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $840.00 | 1 | $0 (2021) |
| Merz Pharmaceuticals, LLC | $286.23 | 6 | $0 (2023) |
| Allergan, Inc. | $231.71 | 22 | $0 (2021) |
| Grifols USA, LLC | $84.15 | 4 | $0 (2024) |
| CSL Behring | $60.43 | 3 | $0 (2021) |
| PFIZER INC. | $59.96 | 2 | $0 (2023) |
| Biogen, Inc. | $58.65 | 1 | $0 (2020) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $50.64 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,048 | 59 | ARGENX US, INC. ($18,330) |
| 2023 | $532.25 | 24 | ABBVIE INC. ($232.26) |
| 2022 | $513.22 | 18 | Merz Pharmaceuticals, LLC ($199.59) |
| 2021 | $1,136 | 23 | Alexion Pharmaceuticals, Inc. ($840.00) |
| 2020 | $102.20 | 4 | Biogen, Inc. ($58.65) |
| 2019 | $83.58 | 4 | Merz North America, Inc. ($28.11) |
| 2018 | $47.25 | 3 | Grifols USA, LLC ($18.45) |
| 2017 | $21.39 | 1 | Grifols USA, LLC ($21.39) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $90.58 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $72.91 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $41.54 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $58.96 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $566.95 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $220.21 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $215.78 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $162.72 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Immunology and Neurology | ||||||
| 11/18/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Neurology | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 229 | 12,995 | $432,823 | $94,727 |
| 2022 | 10 | 199 | 8,578 | $325,382 | $68,798 |
| 2021 | 9 | 206 | 288 | $155,881 | $29,431 |
| 2020 | 11 | 197 | 259 | $122,156 | $21,484 |
Total Patients
831
Total Services
22,120
Medicare Billing
$214,440
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 14 | 12,698 | $254,020 | $63,144 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 91 | $50,050 | $9,811 | 19.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 22 | 22 | $40,348 | $5,937 | 14.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 51 | $27,501 | $4,674 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 21 | $15,645 | $3,370 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $16,949 | $2,694 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 30 | $11,250 | $2,204 | 19.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $9,100 | $1,590 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 13 | $7,150 | $976.43 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 39 | $810.00 | $327.60 | 40.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 8,300 | $166,000 | $40,220 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 88 | $48,400 | $9,309 | 19.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 29 | 56 | $29,904 | $5,507 | 18.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 11 | 11 | $20,174 | $3,079 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 17 | $12,665 | $2,773 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 33 | $12,375 | $2,725 | 22.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $14,916 | $2,307 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $11,964 | $1,703 | 14.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 16 | $8,304 | $1,074 | 12.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 34 | $680.00 | $100.53 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 72 | $39,600 | $8,213 | 20.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 36 | 58 | $31,506 | $6,022 | 19.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 35 | $26,075 | $5,088 | 19.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 14 | 14 | $14,910 | $2,792 | 18.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 30 | $11,250 | $2,580 | 22.9% |
About Dr. Patrick Kwon, M.D
Dr. Patrick Kwon, M.D is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1558669812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Kwon, M.D has received a total of $21,484 in payments from pharmaceutical and medical device companies, with $19,048 received in 2024. These payments were reported across 136 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,500).
As a Medicare-enrolled provider, Kwon has provided services to 831 Medicare beneficiaries, totaling 22,120 services with total Medicare billing of $214,440. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neuromuscular Medicine
- Location Brooklyn, NY
- Active Since 03/09/2011
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1558669812
Products in Payments
- VYVGART HYTRULO (Drug) $16,394
- VYVGART (Drug) $2,194
- BOTOX (Biological) $1,025
- Soliris (Drug) $840.00
- Xeomin (Biological) $286.23
- QULIPTA (Drug) $111.16
- Gamunex-C (Biological) $84.15
- UBRELVY (Drug) $83.84
- Hizentra (Biological) $60.43
- SPINRAZA (Biological) $58.65
- RADICAVA (Drug) $50.64
- XEOMIN (Biological) $46.11
- PANZYGA (Biological) $38.22
- JARDIANCE (Drug) $26.67
- DOVATO (Drug) $25.33
- Plasbumin (Biological) $24.76
- KEVEYIS (Drug) $22.54
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $21.74
- Eprontia (Drug) $21.70
- ONPATTRO (Drug) $20.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680